Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy

被引:51
作者
Dolton, Garry [1 ]
Rius, Cristina [1 ]
Wall, Aaron [1 ]
Szomolay, Barbara [2 ]
Bianchi, Valentina [1 ]
Galloway, Sarah A. E. [1 ]
Hasan, Md Samiul [1 ]
Morin, Theo [1 ]
Caillaud, Marine E. [1 ]
Thomas, Hannah L. [1 ]
Theaker, Sarah [1 ]
Tan, Li Rong [1 ]
Fuller, Anna [1 ]
Topley, Katie [1 ]
Legut, Mateusz [1 ]
Attaf, Meriem [1 ]
Hopkins, Jade R. [1 ]
Behiry, Enas [1 ]
Zabkiewicz, Joanna [3 ]
Alvares, Caroline [3 ]
Lloyd, Angharad [1 ]
Rogers, Amber [1 ]
Henley, Peter [3 ]
Fegan, Christopher [3 ]
Ottmann, Oliver [3 ]
Man, Stephen [3 ]
Crowther, Michael D. [1 ,4 ]
Donia, Marco [4 ]
Svane, Inge Marie [4 ]
Cole, David K. [1 ]
Brown, Paul E. [5 ]
Rizkallah, Pierre [1 ]
Sewell, Andrew K. [1 ,2 ]
机构
[1] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff CF14 4XN, Wales
[2] Wales Heart Res Inst, Cardiff CF14 4XN, Wales
[3] Cardiff Univ, Sch Med, Div Canc & Genet, Cardiff CF14 4XN, Wales
[4] Copenhagen Univ Hosp, Natl Ctr Canc Immune Therapy, Dept Oncol, Herlev, Denmark
[5] Univ Warwick, Zeeman Inst, Coventry CV4 7AL, England
基金
英国医学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
BINDING-AFFINITY; PEPTIDE; EXPRESSION; CRYSTALLIZATION; OVEREXPRESSION; REGRESSION; MELANOMA; THERAPY; GENE; RECOGNITION;
D O I
10.1016/j.cell.2023.06.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The T cells of the immune system can target tumors and clear solid cancers following tumor-infiltrating lymphocyte (TIL) therapy. We used combinatorial peptide libraries and a proteomic database to reveal the antigen specificities of persistent cancer-specific T cell receptors (TCRs) following successful TIL therapy for stage IV malignant melanoma. Remarkably, individual TCRs could target multiple different tumor types via the HLA A*02:01-restricted epitopes EAAGIGILTV, LLLGIGILVL, and NLSALGIFST from Melan A, BST2, and IMP2, respectively. Atomic structures of a TCR bound to all three antigens revealed the importance of the shared x-x-x-A/G-I/L-G-I-x-x-x recognition motif. Multi-epitope targeting allows individual T cells to attack cancer in several ways simultaneously. Such "multipronged"T cells exhibited superior recognition of cancer cells compared with conventional T cell recognition of individual epitopes, making them attractive candidates for the development of future immunotherapies.
引用
收藏
页码:3333 / +
页数:45
相关论文
共 78 条
  • [1] T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression
    Andersen, R.
    Borch, T. H.
    Draghi, A.
    Gokuldass, A.
    Rana, M. A. H.
    Pedersen, M.
    Nielsen, M.
    Kongsted, P.
    Kjeldsen, J. W.
    Westergaard, M. C. W.
    Radic, H. D.
    Chamberlain, C. A.
    Holmich, L. R.
    Hendel, H. W.
    Larsen, M. S.
    Met, O.
    Svane, I. M.
    Donia, M.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (07) : 1575 - 1581
  • [2] Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
    Andersen, Rikke
    Donia, Marco
    Ellebaek, Eva
    Borch, Troels Holz
    Kongsted, Per
    Iversen, Trine Zeeberg
    Holmich, Lisbet Rosenkrantz
    Hendel, Helle Westergren
    Met, Ozcan
    Andersen, Mads Hald
    Straten, Per Thor
    Svane, Inge Marie
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3734 - 3745
  • [3] Overexpression of IGF2 mRNA-Binding Protein 2 (IMP2/p62) as a Feature of Basal-like Breast Cancer Correlates with Short Survival
    Barghash, A.
    Helms, V.
    Kessler, S. M.
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2015, 82 (02) : 142 - 143
  • [4] Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma
    Barghash, Ahmad
    Golob-Schwarzl, Nicole
    Helms, Volkhard
    Haybaeck, Johannes
    Kessler, Sonja M.
    [J]. ONCOTARGET, 2016, 7 (31) : 49743 - 49750
  • [5] Berset M, 2001, INT J CANCER, V95, P73, DOI 10.1002/1097-0215(20010120)95:1<73::AID-IJC1013>3.3.CO
  • [6] 2-J
  • [7] MiXCR: software for comprehensive adaptive immunity profiling
    Bolotin, Dmitriy A.
    Poslavsky, Stanislav
    Mitrophanov, Igor
    Shugay, Mikhail
    Mamedov, Ilgar Z.
    Putintseva, Ekaterina V.
    Chudakov, Dmitriy M.
    [J]. NATURE METHODS, 2015, 12 (05) : 380 - 381
  • [8] Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
    Borch, Troels Holz
    Andersen, Rikke
    Ellebaek, Eva
    Met, Ozcan
    Donia, Marco
    Marie Svane, Inge
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [9] Stable, soluble T-cell receptor molecules for crystallization and therapeutics
    Boulter, JM
    Glick, M
    Todorov, PT
    Baston, E
    Sami, M
    Rizkallah, P
    Jakobsen, BK
    [J]. PROTEIN ENGINEERING, 2003, 16 (09): : 707 - 711
  • [10] TCR/pMHC Optimized Protein crystallization Screen
    Bulek, Anna M.
    Madura, Florian
    Fuller, Anna
    Holland, J.
    Schauenburg, Andrea J. A.
    Sewell, Andrew K.
    Rizkallah, Pierre J.
    Cole, David K.
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2012, 382 (1-2) : 203 - 210